GE Healthcare Technologies Inc logo

GE Healthcare Technologies Inc (GEHC)

Market Closed
10 Feb, 11:55
COL$
360,520. 00
-8,920
-2.41%
COL$
- Market Cap
28.36 P/E Ratio
0.12% Div Yield
10 Volume
4.3 Eps
COL$ 369.44K
Previous Close
Day Range
360,520 360,520
Year Range
300,000 388,400
Earnings results expected in 75 days

Summary

GEHC closed Monday lower at COL$360,520, a decrease of 2.41% from Friday's close, completing a monthly increase of 3.01% or COL$10,520. Over the past 12 months, GEHC stock gained 3.01%.
GEHC pays dividends to its shareholders, with the most recent payment made on 12 hours ago. The next estimated payment will be in In 3 months on May 14, 2025 for a total of COL$0.035.
The last earnings report, released on Oct 30, 2024, exceeded the consensus estimates by 0.09%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports. The next scheduled earnings report is due on Apr 30, 2025.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on BVC (COP).
Want to track GEHC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

GEHC Chart

GE Healthcare Technologies Inc (GEHC) FAQ

What is the stock price today?

The current price is COL$360,520.00.

On which exchange is it traded?

GE Healthcare Technologies Inc is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is GEHC.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Apr 30, 2025.

Has GE Healthcare Technologies Inc ever had a stock split?

No, there has never been a stock split.

GE Healthcare Technologies Inc Profile

Health Information Services Industry
Healthcare Sector
Mr. Peter J. Arduini CEO
BVC Exchange
US36266G1076 ISIN
United States Country
51,000 Employees
14 Jan 2025 Last Dividend
- Last Split
4 Jan 2023 IPO Date

Overview

GE HealthCare Technologies Inc. is a globally recognized company deeply engaged in the healthcare sector, providing a wide range of products, services, and digital solutions aimed at improving patient care. With operations spread across the United States, Canada, and other international markets, the company commits itself to the development, manufacture, and marketing of innovative medical technologies. The organizational structure of GE HealthCare Technologies Inc. is divided into four primary segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, each dedicated to addressing specific medical needs and advancing the field of medical diagnostics and patient care. Having evolved from GE Healthcare Holding LLC in December 2022, the company is now based in Chicago, Illinois, and continues to leverage its broad portfolio to facilitate the diagnosis, treatment, and monitoring of patients worldwide.

Products and Services

  • Imaging

    This segment provides a comprehensive range of imaging technologies such as molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. These advanced imaging solutions play a crucial role in diagnosing and managing various health conditions, enhancing the efficiency and effectiveness of medical treatments.

  • Ultrasound

    GE HealthCare Technologies Inc. offers a wide array of ultrasound devices and solutions designed for screening, diagnosis, treatment, and monitoring of diseases in numerous clinical areas. This includes radiology, primary care, women's health, cardiovascular, along with point of care and handheld ultrasound devices, and products for surgical visualization and guidance. Ultrasound technology facilitates non-invasive diagnostics and therapeutic procedures, making it an essential tool in modern healthcare.

  • Patient Care Solutions

    The company's offerings under this segment encompass a variety of medical devices, consumables, services, and digital solutions aimed at improving patient outcomes. The portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, and maternal infant care products, alongside a range of consumables and services. These solutions are integral to providing comprehensive care in various medical settings, from emergency rooms to intensive care units and beyond.

  • Pharmaceutical Diagnostics

    Specializing in diagnostic agents for radiology and nuclear medicine, this segment supplies essential products for CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound imaging. The products include contrast media pharmaceuticals that improve the visibility of tissues during diagnostic scans and molecular imaging agents or radiopharmaceuticals labeled with radioisotopes for detailed imaging studies. These diagnostic agents are pivotal in detecting and monitoring a wide range of diseases, aiding clinicians in formulating effective treatment plans.

Contact Information

Address: 500 West Monroe Street
Phone: 833 735 1139